Comerica Bank’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4M Buy
31,825
+106
+0.3% +$13.3K 0.02% 776
2025
Q1
$3.51M Sell
31,719
-1,727
-5% -$191K 0.01% 834
2024
Q4
$4.57M Sell
33,446
-1,395
-4% -$190K 0.02% 727
2024
Q3
$4.01M Sell
34,841
-117,983
-77% -$13.6M 0.02% 801
2024
Q2
$21M Buy
152,824
+17,178
+13% +$2.36M 0.09% 213
2024
Q1
$18.7M Sell
135,646
-14,778
-10% -$2.04M 0.08% 240
2023
Q4
$19.8M Sell
150,424
-5,058
-3% -$666K 0.09% 202
2023
Q3
$17.5M Buy
155,482
+137,338
+757% +$15.5M 0.09% 201
2023
Q2
$60 Buy
+18,144
New +$60 0.01% 165
2022
Q4
$9.68M Sell
89,412
-25,890
-22% -$2.8M 0.08% 288
2022
Q3
$12.7M Sell
115,302
-9,619
-8% -$1.06M 0.11% 174
2022
Q2
$12M Sell
124,921
-10,775
-8% -$1.04M 0.1% 191
2022
Q1
$13.3M Sell
135,696
-23,002
-14% -$2.26M 0.1% 192
2021
Q4
$12.1M Buy
158,698
+12,079
+8% +$917K 0.09% 217
2021
Q3
$15.2M Buy
146,619
+1,889
+1% +$196K 0.09% 206
2021
Q2
$13M Buy
144,730
+29,856
+26% +$2.67M 0.08% 244
2021
Q1
$11.1M Buy
114,874
+73,869
+180% +$7.14M 0.07% 314
2020
Q4
$4.79M Buy
41,005
+21,933
+115% +$2.56M 0.03% 722
2020
Q3
$1.89M Buy
19,072
+4,200
+28% +$416K 0.01% 1160
2020
Q2
$1.94M Sell
14,872
-3,427
-19% -$447K 0.01% 1099
2020
Q1
$1.8M Buy
18,299
+14,021
+328% +$1.38M 0.02% 984
2019
Q4
$434K Buy
4,278
+345
+9% +$35K ﹤0.01% 1950
2019
Q3
$386K Buy
3,933
+125
+3% +$12.3K ﹤0.01% 1972
2019
Q2
$335K Sell
3,808
-10,848
-74% -$954K ﹤0.01% 2031
2019
Q1
$1.34M Buy
14,656
+6,002
+69% +$548K 0.01% 1392
2018
Q4
$736K Buy
8,654
+5,549
+179% +$472K 0.01% 1709
2018
Q3
$337K Sell
3,105
-159
-5% -$17.3K ﹤0.01% 2024
2018
Q2
$341K Sell
3,264
-20
-0.6% -$2.09K ﹤0.01% 2036
2018
Q1
$257K Sell
3,284
-46
-1% -$3.6K ﹤0.01% 2116
2017
Q4
$295K Sell
3,330
-46
-1% -$4.08K ﹤0.01% 2094
2017
Q3
$210K Buy
+3,376
New +$210K ﹤0.01% 2165